Open Access

Cluster headache with Brugada electrocardiogram pattern: a case report

  • Yuka Matsuki1,
  • Munetaka Hirose1Email author,
  • Akira Nakano2,
  • Katsuhiko Sarasawa2 and
  • Toshio Hamada3
The Journal of Headache and Pain20089:49

https://doi.org/10.1007/s10194-008-0049-3

Received: 1 May 2008

Accepted: 4 June 2008

Published: 19 June 2008

Abstract

Agents including the effect on sodium channel are restricted in patients with Brugada electrocardiogram (ECG) pattern or Brugada syndrome. On the other hand, many therapeutic agents for cluster headache (CH) block sodium channel. After recommended therapies without sodium channel blocking effect were failed in a 40-year-old male with CH whose ECG shows Brugada ECG pattern, clonazepam and codein phosphate, which are exceptional treatments for CH, were effective for severe unilateral orbital pain.

Keywords

Brugada electrocardiogram patternClonazepamCluster headacheCodein

Introduction

Cluster headache (CH) is one of the syndromes of trigeminal autonomic cephalalgias, which is characterized by severe unilateral pain localized to orbital, temporal, and midface areas accompanied by typical autonomic symptoms [1]. On the other hand, Brugada syndrome is known for a cause of sudden death due to ventricular fibrillation, and is characterized by ST-segment elevation in the precordial electrocardiogram (ECG) leads (V1–3) associated with right bundle branch block [2, 3]. The same ECG pattern in patients without clinical symptoms (e.g., syncope, cardiac arrest, family history, etc.) is diagnosed as Brugada ECG pattern [4, 5]. Prevalence of CH is estimated to be 0.1–0.4% [1] and that of Brugada ECG pattern is 0.1% [5]. Therefore, a case of CH with Brugada ECG pattern is likely very rare.

Agents including the effect of sodium channel block are restricted in patients with Brugada ECG pattern or Brugada syndrome, as these have the potential to induce sudden cardiac arrest. Many treatments for CH, however, include sodium channel blocking effect, such as local anesthetics, lithium, and verapamil [1, 6]. Therefore, it would be difficult to treat severe headache in a case for CH patient accompanied with either Brugada syndrome or Brugada ECG pattern, especially if therapies without the effect on sodium channel were failed.

Case report

A 40-year-old Japanese male, who was diagnosed with Brugada ECG pattern (Fig. 1), was complained of CH. He had no history of ventricular tachycardia/fibrillation and familial sudden cardiac death.
Fig. 1

Saddle-back type ST-segment elevation in lead V2

The characteristics of pain was a severe right orbital pain occurring spontaneously at least one time in a day, lasting for 3 months in a year. This headache associated with tearing eyes and rhinorrhea. Alcohol intake aggravated the attacks of pain. Sumatriptan or oxygen inhalation had been used for symptomatic treatment, and prednisolone and valproic acid had been used as preventive treatment for over 10 years in Fukui Prefectural Hospital. Severity of headache, however, has been aggravated gradually in spite of these treatments, and he was inquired for further treatment in Pain Clinic in University of Fukui, Faculty of Medical Sciences.

Although we prescribed zolmitriptan (2.5 mg p.o.) for attack and lomerizine (10–20 mg/day p.o.) for prevention at first, severity of headache and the number of attacks showed no change after prescription for 2 weeks. Local anesthestics for nasal instillation and nerve blocks, and also verapamil were not selected, because these agents block sodium channel and can induce lethal arrhythmias in a patient with Brugada syndrome or Brugada ECG pattern [711]. Then, we selected clonazepam and codein phosphate, which are exceptional treatments for CH [6, 1214]. Clonazepam (2 mg/day p.o.) and codein phosphate (120 mg/day p.o.) suppressed severity of headache dramatically without ECG change. Frequency of attacks, however, showed no change.

Discussion

The ECG patterns in Brugada syndrome are divided into two types in association with a shape of ST-segment elevation; coved- and saddle-back type. Sodium channel gene mutations are associated with Brugada syndrome, and therapeutic use of agents including sodium channel blocking effect is prohibited as it can induce ventricular fibrillation [2, 3]. Individuals with Brugada ECG pattern also have a risk of sudden death [4]. Local anesthetics block sodium channel. Epidural anesthesia with bupivacaine unmasked a subclinical form of Brugada ECG pattern or Brugada syndrome [7, 8]. Thoracic paravertebral block with ropivacaine induced ventricular tachycardia in a patient with Brugada syndrome [9]. Verapamil, a calcium blocker, also blocks sodium channel. Verapamil, used in patient with Brugada syndrome, caused ventricular fibrillation [10, 11].

Treatments for CH is divided into acute therapy aimed at aborting individual attacks and prophylactic therapy aimed at preventing recurrent attacks [1, 6]. Acute therapy includes inhalation of 100% oxygen, nasal instillation of lidocain, subcutaneous sumatriptan, and ergot derivatives. As preventive therapy, there are verapamil, lithium, corticosteroids, and nonsurgical and surgical procedures (e.g., greater occipital nerve block, neurostimulation of the occipital nerve) [1, 6]. Among these recommended therapeutics, nasal instillation of lidocaine, nerve block with local anesthetics, and verapamil cannot be used in patients of CH accompanying with Brugada syndrome.

Clinical management with regard to the treatment for sudden cardiac death of asymptomatic patients with Brugada ECG pattern has yet to be determined [5]. Not all patients with Brugada ECG pattern are affected by Brugada syndrome. Mediastinal tumor is reported to cause Brugada ECG pattern [15]. Therefore, if careful examination eliminated a risk of sudden cardiac death in patients with both CH and Brugada ECG pattern, therapeutic agents for CH including sodium channel blocking effect could be used in these patients.

We treated a patient suffering from CH associated with Brugada ECG pattern, after the recommended therapeutics without the effect of sodium channel block were failed. As a risk of sudden cardiac death was not completely eliminated in this patient, we decided not to use agents including sodium channel blocking effect. Prescription of clonazepam and codein phosphate decreased the intensity of headache, although frequency of the attack showed no change. Both opioids and anticonvulsants without sodium channel blocking effects, such as clonazepam, gabapentin, and baclofen might be a therapeutic choice for CH accompanied with Brugada syndrome or Brugada electrocardiogram pattern. Surgical procedures, such as neurostimulation of the occipital nerve, might also be substituted for the treatment in this patient.

Declarations

Conflict of interest

None.

Authors’ Affiliations

(1)
Department of Anesthesiology and Reanimatology, Faculty of Medical Sciences, University of Fukui
(2)
First Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui
(3)
Department of Neurology, Fukui Prefectural Hospital

References

  1. Balasubramaniam R, Klasser GD (2007) Trigeminal autonomic cephalalgias. Part 1: cluster headache. Med Oral Pathol Oral Radiol Endod 104:345–358 10.1016/j.tripleo.2007.03.010View ArticleGoogle Scholar
  2. Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA, Brugada P (2000) Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 101:510–515 10662748, 1:STN:280:DC%2BD3c7ivFyrsQ%3D%3DView ArticlePubMedGoogle Scholar
  3. Francis J, Antzelevitch C (2005) Brugada syndrome. Int J Cardiol 101:173–178 15882659, 10.1016/j.ijcard.2004.03.068PubMed CentralView ArticlePubMedGoogle Scholar
  4. Brugada J, Brugada R, Brugada P (2003) Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 108:3092–3096 14623800, 10.1161/01.CIR.0000104568.13957.4FView ArticlePubMedGoogle Scholar
  5. Di Grande A, Tomaselli V, Massarelli L, Amico S, Bellanuova I, Barbera A (2006) Brugada-like electrocardiographic pattern: a challenge for the clinician. Eur J Intern Med 17:3–7 16378878, 10.1016/j.ejim.2005.07.010View ArticlePubMedGoogle Scholar
  6. Saper JR, Silberstein SD, Gordon CD, Hamel RL, Swidan S (1999) Handbook of headache management, 2nd edn. Lippincott Williams & Wilkins, BaltimoreGoogle Scholar
  7. Phillips N, Priestley M, Denniss R, Uther JB (2003) Brugada-type electrocardiographic pattern induced by epidural bupivacaine. Anesth Analg 97:264–267 12818979, 10.1213/01.ANE.0000067410.32384.3AView ArticlePubMedGoogle Scholar
  8. Vernooy K, Sicouri S, Dumaine R, Hong K, Oliva A, Burashnikov E, Timmermans C, Delhaas T, Crijns HJGM, Antzelevitch C, Rodriguez L-M, Brugada R (2006) Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome. Heart Rhythm 3:1074–1078 16945804, 10.1016/j.hrthm.2006.05.030PubMed CentralView ArticlePubMedGoogle Scholar
  9. Fujiwara Y, Shibata Y, Kurokawa S, Satou Y, Komatsu T (2006) Ventricular tachycardia in a patient with Brugada syndrome during general anesthesia combined with thoracic paravertebral block. Anesth Analg 102:1590–1591 16632856, 10.1213/01.ANE.0000215196.42122.05View ArticlePubMedGoogle Scholar
  10. Fish JM, Antzelevitch C (2004) Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm 1:210–217 15851155, 10.1016/j.hrthm.2004.03.061PubMed CentralView ArticlePubMedGoogle Scholar
  11. Chinushi M, Tagawa M, Nakamura Y, Aizawa Y (2006) Shortening of the ventricular fibrillatory intervals after administration of verapamil in a patient with Brugada syndrome and vasospastic angina. J Electrocardiol 39:331–335 16777521, 10.1016/j.jelectrocard.2005.10.002View ArticlePubMedGoogle Scholar
  12. Caccia MR (1975) Clonazepam in facial neuralgia and cluster headache. Clinical and electrophysiological study. Eur J Neurol 13:560–563 10.1159/000114712, 1:STN:280:CSmD28nhtlE%3DView ArticleGoogle Scholar
  13. Sicuteri F, Raino L, Geppetti P (1983) Substance P and endogenous opioids: how and where they could play a role in cluster headache. Cephalalgia 3(suppl 1):143–145 6193886PubMedGoogle Scholar
  14. Takebayashi M, Fujikawa T, Kagaya A, Horiguchi J, Yamawaki S (1999) Lithium and clonazepam treatment of two cases with cluster headache. Psychiatry Clin Neurosci 53:535–537 10498239, 10.1046/j.1440-1819.1999.00573.x, 1:STN:280:DyaK1Mvis1GhtQ%3D%3DView ArticlePubMedGoogle Scholar
  15. Tarin N, Farre J, Rubio JM, Tunon J, Castro-Dorticos J (1999) Brugada-like electrocardiographic pattern in a patient with a mediastinal tumor. Pacing Clin Electrophysiol 22:1264–1266 10461308, 10.1111/j.1540-8159.1999.tb00613.x, 1:STN:280:DyaK1MzptVCjuw%3D%3DView ArticlePubMedGoogle Scholar

Copyright

© Springer-Verlag 2008